Top-News

ALLIGATOR BIOSC. AB O.N. News

Aktie
WKN:  A2AN1Z ISIN:  SE0000767188
0,0953 €
+0,0023 €
+2,47%
10:31:46 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

ALLIGATOR BIOSC. AB O.N. News

30.06.21 - PR Newswire
Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data
Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data PR Newswire
30.06.21 - PR Newswire
Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data
Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data PR Newswire
07.06.21 - PR Newswire
Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy
Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy PR Newswire
07.06.21 - PR Newswire
Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy
Article on CD40 agonistic antibodies published in Expert Opinion on Biological Therapy PR Newswire
04.06.21 - PR Newswire
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017 PR Newswire
04.06.21 - PR Newswire
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017 PR Newswire
05.05.21 - PR Newswire
Alligator's mitazalimab shown to enhance cancer vaccine
Alligator's mitazalimab shown to enhance cancer vaccine PR Newswire
04.05.21 - PR Newswire
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field PR Newswire
04.05.21 - PR Newswire
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field PR Newswire
27.04.21 - PR Newswire
Alligator Bioscience AB: Interim report January-March 2021
Alligator Bioscience AB: Interim report January-​March 2021 PR Newswire
27.04.21 - PR Newswire
Alligator Bioscience AB: Interim report January-March 2021
Alligator Bioscience AB: Interim report January-​March 2021 PR Newswire
22.04.21 - PR Newswire
The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB PR Newswire
22.04.21 - PR Newswire
The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB PR Newswire
15.04.21 - PR Newswire
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy PR Newswire
15.04.21 - PR Newswire
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy PR Newswire
03.04.21 - PR Newswire
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021 PR Newswire
03.04.21 - PR Newswire
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021 PR Newswire
18.03.21 - PR Newswire
Alligator Bioscience appoints Søren Bregenholt as new CEO
Alligator Bioscience appoints Søren Bregenholt as new CEO PR Newswire
18.03.21 - PR Newswire
Alligator Bioscience appoints Søren Bregenholt as new CEO
Alligator Bioscience appoints Søren Bregenholt as new CEO PR Newswire
18.03.21 - PR Newswire
Alligator Bioscience publishes Annual Report for 2020
Alligator Bioscience publishes Annual Report for 2020 PR Newswire

Newssuche

Videos

29.05.24 +31,94%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »